⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12207306 | 0.72 | — | — | |
| SCHEMBL16230411 | 0.72 | — | — | |
| SCHEMBL48190 | 0.61 | — | — | |
| SCHEMBL172102 | 0.61 | — | — | |
| Methylsulfanylmethane SCHEMBL6558838 | 0.58 | — | — | |
| SCHEMBL6897693 | 0.55 | — | — | |
| Ammonia Solution, Strong SCHEMBL10611826 | 0.55 | — | — | |
| SCHEMBL10039326 | 0.55 | — | — | |
| Hydrogen Sulfide SCHEMBL2121945 | 0.55 | — | — | |
| Bromide SCHEMBL9080847 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 216 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240308936-A1 | METHOD FOR PRODUCING ALPHA-OLEFIN OLIGOMER COMPOSITION | IDEMITSU KOSAN CO.,LTD. (JP) | 2024-09-19 | — | — | US | disclosed |
| US-12037355-B2 | Triterpene saponin analogues | ADJUVANCE TECHNOLOGIES, INC. (US) | 2024-07-16 | — | — | US | disclosed |
| EP-4385972-A1 | METHOD FOR PRODUCING ALPHA-OLEFIN OLIGOMER COMPOSITION | Idemitsu Kosan Co.,Ltd. (JP) | 2024-06-19 | — | — | EP | disclosed |
| CN-117751107-A | Organic pyridine-pyrazole compounds and uses thereof | 博善人工智能剑桥有限公司 | 2024-03-22 | — | — | CN | disclosed |
| US-20240025862-A1 | SUBSTITUTED N-PHENYLURACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES | BAYER AKTIENGESELLSCHAFT (DE) | 2024-01-25 | — | — | US | disclosed |
| US-20230398224-A1 | TARGETED PLASMA PROTEIN DEGRADATION | NOVARTIS AG (CH) | 2023-12-14 | — | — | US | disclosed |
| US-11806409-B2 | Imaging methods using 18F-radiolabeled biologics | BRISTOL-MYERS SQUIBB COMPANY (US) | 2023-11-07 | — | — | US | disclosed |
| US-20230320995-A1 | IONIZABLE CATIONIC LIPIDS AND LIPID NANOPARTICLES | CAPSTAN THERAPEUTICS, INC. (US) | 2023-10-12 | — | — | US | disclosed |
| US-11780836-B2 | Process of preparing a PD-1/PD-L1 inhibitor | INCYTE CORPORATION (US) | 2023-10-10 | — | — | US | disclosed |
| US-20230303526-A1 | IRAK DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2023-09-28 | — | — | US | disclosed |
| US-20100167554-A1 | METHODS FORMING HIGH DIELECTRIC TARGET LAYER | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2010-07-01 | — | — | US | disclosed |
| US-20100125069-A1 | Methods of Treating or Preventing Autoimmune Diseases with 2,4-Pyrimidinediamine Compounds | RIGEL PHARMACEUTICALS INC. (US) | 2010-05-20 | — | — | US | disclosed |
| US-20090320152-A1 | MUTATION BREEDING FOR RESISTANCE TO DISEASE AND OTHER USEFUL TRAITS | WASHINGTON STATE UNIVERSITY (US) | 2009-12-24 | — | — | US | disclosed |
| EP-2128910-A1 | ORGANIC EL DEVICE AND DISPLAY | Idemitsu Kosan Co., Ltd. (JP) | 2009-12-02 | — | — | EP | disclosed |
| US-20090280139-A1 | Novel Norovirus Particle for Use as an Antiviral or Vaccine | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-11-12 | — | — | US | disclosed |
| US-20090098438-A1 | ION CONDUCTIVE MATERIAL, CONDUCTIVE FILM FOR FUEL CELL, FILM ELECTRODE BONDED BODY AND FUEL CELL | RIKEN (JP) | 2009-04-16 | — | — | US | disclosed |
| US-20080200980-A1 | PROFILE REDUCTION OF VALVE IMPLANT | DIRECT FLOW (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC | 2008-08-21 | — | — | US | disclosed |
| US-20070287800-A1 | Lubricious Compounds For Biomedical Applications Using Hydrophilic Polymers | FOSTER CORPORATION (US) | 2007-12-13 | — | — | US | disclosed |
| US-20070134328-A1 | OXYMORPHONE CONTROLLED RELEASE FORMULATIONS | ENDO PHARMACEUTICALS, INC. (US) | 2007-06-14 | — | — | US | disclosed |
| US-20070088088-A1 | Method for preventing or treating metabolic syndrome | KISSEI PHARMACEUTICAL CO., LTD. | 2007-04-19 | — | — | US | disclosed |